BIO-TECHNE CORP (TECH) Stock Fundamental Analysis
NASDAQ:TECH • US09073M1045
57.52 USD
-0.73 (-1.25%)
At close: Feb 20, 2026
57.52 USD
0 (0%)
After Hours: 2/20/2026, 8:07:03 PM
Taking everything into account, TECH scores 6 out of 10 in our fundamental rating. TECH was compared to 58 industry peers in the Life Sciences Tools & Services industry. TECH gets an excellent profitability rating and is at the same time showing great financial health properties. TECH has a decent growth rate and is not valued too expensively. With these ratings, TECH could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
- TECH had positive earnings in the past year.
- In the past year TECH had a positive cash flow from operations.
- TECH had positive earnings in each of the past 5 years.
- Each year in the past 5 years TECH had a positive operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of 3.17%, TECH is in the better half of the industry, outperforming 74.14% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 3.98%, TECH is in the better half of the industry, outperforming 74.14% of the companies in the same industry.
- TECH has a better Return On Invested Capital (9.52%) than 87.93% of its industry peers.
- TECH had an Average Return On Invested Capital over the past 3 years of 9.00%. This is below the industry average of 12.04%.
- The last Return On Invested Capital (9.52%) for TECH is above the 3 year average (9.00%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 3.98% | ||
| ROIC | 9.52% |
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
1.3 Margins
- With a decent Profit Margin value of 6.58%, TECH is doing good in the industry, outperforming 74.14% of the companies in the same industry.
- TECH's Profit Margin has declined in the last couple of years.
- TECH's Operating Margin of 22.59% is amongst the best of the industry. TECH outperforms 93.10% of its industry peers.
- TECH's Operating Margin has been stable in the last couple of years.
- TECH has a Gross Margin of 66.60%. This is amongst the best in the industry. TECH outperforms 87.93% of its industry peers.
- In the last couple of years the Gross Margin of TECH has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.59% | ||
| PM (TTM) | 6.58% | ||
| GM | 66.6% |
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TECH is destroying value.
- The number of shares outstanding for TECH has been reduced compared to 1 year ago.
- TECH has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, TECH has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 12.38 indicates that TECH is not in any danger for bankruptcy at the moment.
- TECH's Altman-Z score of 12.38 is amongst the best of the industry. TECH outperforms 96.55% of its industry peers.
- The Debt to FCF ratio of TECH is 1.17, which is an excellent value as it means it would take TECH, only 1.17 years of fcf income to pay off all of its debts.
- TECH has a Debt to FCF ratio of 1.17. This is amongst the best in the industry. TECH outperforms 89.66% of its industry peers.
- A Debt/Equity ratio of 0.13 indicates that TECH is not too dependend on debt financing.
- TECH's Debt to Equity ratio of 0.13 is fine compared to the rest of the industry. TECH outperforms 60.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 1.17 | ||
| Altman-Z | 12.38 |
ROIC/WACC0.88
WACC10.86%
2.3 Liquidity
- TECH has a Current Ratio of 4.54. This indicates that TECH is financially healthy and has no problem in meeting its short term obligations.
- The Current ratio of TECH (4.54) is better than 72.41% of its industry peers.
- TECH has a Quick Ratio of 3.08. This indicates that TECH is financially healthy and has no problem in meeting its short term obligations.
- TECH has a Quick ratio (3.08) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.54 | ||
| Quick Ratio | 3.08 |
3. Growth
3.1 Past
- TECH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.84%, which is quite good.
- Measured over the past years, TECH shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.25% on average per year.
- Looking at the last year, TECH shows a small growth in Revenue. The Revenue has grown by 1.64% in the last year.
- Measured over the past years, TECH shows a quite strong growth in Revenue. The Revenue has been growing by 10.55% on average per year.
EPS 1Y (TTM)8.84%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%9.52%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%0.24%
3.2 Future
- Based on estimates for the next years, TECH will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.61% on average per year.
- Based on estimates for the next years, TECH will show a small growth in Revenue. The Revenue will grow by 7.10% on average per year.
EPS Next Y4.66%
EPS Next 2Y7.87%
EPS Next 3Y10.61%
EPS Next 5Y8.61%
Revenue Next Year0.56%
Revenue Next 2Y3.68%
Revenue Next 3Y5.76%
Revenue Next 5Y7.1%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 29.20, which means the current valuation is very expensive for TECH.
- Based on the Price/Earnings ratio, TECH is valued a bit cheaper than the industry average as 62.07% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Earnings ratio of 26.99, TECH is valued at the same level.
- The Price/Forward Earnings ratio is 25.61, which means the current valuation is very expensive for TECH.
- 68.97% of the companies in the same industry are more expensive than TECH, based on the Price/Forward Earnings ratio.
- TECH is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.2 | ||
| Fwd PE | 25.61 |
4.2 Price Multiples
- TECH's Enterprise Value to EBITDA is on the same level as the industry average.
- TECH's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. TECH is cheaper than 63.79% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 40.35 | ||
| EV/EBITDA | 24.32 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The decent profitability rating of TECH may justify a higher PE ratio.
PEG (NY)6.27
PEG (5Y)2.6
EPS Next 2Y7.87%
EPS Next 3Y10.61%
5. Dividend
5.1 Amount
- With a yearly dividend of 0.54%, TECH is not a good candidate for dividend investing.
- TECH's Dividend Yield is rather good when compared to the industry average which is at 0.10. TECH pays more dividend than 94.83% of the companies in the same industry.
- With a Dividend Yield of 0.54, TECH pays less dividend than the S&P500 average, which is at 1.81.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.54% |
5.2 History
- The dividend of TECH has a limited annual growth rate of 0.11%.
- TECH has paid a dividend for at least 10 years, which is a reliable track record.
- TECH has decreased its dividend recently.
Dividend Growth(5Y)0.11%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
- TECH pays out 62.38% of its income as dividend. This is not a sustainable payout ratio.
- The dividend of TECH is growing, but earnings are growing more, so the dividend growth is sustainable.
DP62.38%
EPS Next 2Y7.87%
EPS Next 3Y10.61%
57.52
-0.73 (-1.25%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-04 2026-02-04/bmo
Earnings (Next)05-05 2026-05-05/bmo
Inst Owners107.49%
Inst Owner Change2.75%
Ins Owners0.25%
Ins Owner Change1.58%
Market Cap9.00B
Revenue(TTM)1.22B
Net Income(TTM)79.96M
Analysts81.74
Price Target71.44 (24.2%)
Short Float %6.31%
Short Ratio4.54
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.54% |
Yearly Dividend0.32
Dividend Growth(5Y)0.11%
DP62.38%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.96%
Min EPS beat(2)-2.04%
Max EPS beat(2)3.95%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-2.04%
Max EPS beat(4)7.36%
EPS beat(8)6
Avg EPS beat(8)3.61%
EPS beat(12)6
Avg EPS beat(12)1.11%
EPS beat(16)7
Avg EPS beat(16)-2.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.79%
Min Revenue beat(2)-3.53%
Max Revenue beat(2)-0.04%
Revenue beat(4)0
Avg Revenue beat(4)-1.87%
Min Revenue beat(4)-3.53%
Max Revenue beat(4)-0.04%
Revenue beat(8)3
Avg Revenue beat(8)-0.65%
Revenue beat(12)3
Avg Revenue beat(12)-1.76%
Revenue beat(16)4
Avg Revenue beat(16)-2.17%
PT rev (1m)0.26%
PT rev (3m)5.24%
EPS NQ rev (1m)-3.7%
EPS NQ rev (3m)-4.29%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.16%
Revenue NQ rev (1m)-1.44%
Revenue NQ rev (3m)-1.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.2 | ||
| Fwd PE | 25.61 | ||
| P/S | 7.4 | ||
| P/FCF | 40.35 | ||
| P/OCF | 36.09 | ||
| P/B | 4.47 | ||
| P/tB | 12.94 | ||
| EV/EBITDA | 24.32 |
EPS(TTM)1.97
EY3.42%
EPS(NY)2.25
Fwd EY3.9%
FCF(TTM)1.43
FCFY2.48%
OCF(TTM)1.59
OCFY2.77%
SpS7.77
BVpS12.85
TBVpS4.45
PEG (NY)6.27
PEG (5Y)2.6
Graham Number23.87
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 3.98% | ||
| ROCE | 11.53% | ||
| ROIC | 9.52% | ||
| ROICexc | 10.26% | ||
| ROICexgc | 25.36% | ||
| OM | 22.59% | ||
| PM (TTM) | 6.58% | ||
| GM | 66.6% | ||
| FCFM | 18.35% |
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
ROICexc(3y)9.68%
ROICexc(5y)10.59%
ROICexgc(3y)24.93%
ROICexgc(5y)34.08%
ROCE(3y)10.9%
ROCE(5y)11.68%
ROICexgc growth 3Y-19.18%
ROICexgc growth 5Y-3.96%
ROICexc growth 3Y-9.13%
ROICexc growth 5Y5.53%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
F-Score8
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 1.17 | ||
| Debt/EBITDA | 0.69 | ||
| Cap/Depr | 25.35% | ||
| Cap/Sales | 2.16% | ||
| Interest Coverage | 15.32 | ||
| Cash Conversion | 65.89% | ||
| Profit Quality | 278.92% | ||
| Current Ratio | 4.54 | ||
| Quick Ratio | 3.08 | ||
| Altman-Z | 12.38 |
F-Score8
WACC10.86%
ROIC/WACC0.88
Cap/Depr(3y)40.04%
Cap/Depr(5y)43.01%
Cap/Sales(3y)3.78%
Cap/Sales(5y)4.03%
Profit Quality(3y)188.66%
Profit Quality(5y)177.71%
High Growth Momentum
Growth
EPS 1Y (TTM)8.84%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%9.52%
EPS Next Y4.66%
EPS Next 2Y7.87%
EPS Next 3Y10.61%
EPS Next 5Y8.61%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%0.24%
Revenue Next Year0.56%
Revenue Next 2Y3.68%
Revenue Next 3Y5.76%
Revenue Next 5Y7.1%
EBIT growth 1Y9.53%
EBIT growth 3Y-3.81%
EBIT growth 5Y11.98%
EBIT Next Year15.61%
EBIT Next 3Y13.34%
EBIT Next 5Y8.56%
FCF growth 1Y-1.07%
FCF growth 3Y-2.92%
FCF growth 5Y10.82%
OCF growth 1Y-9.8%
OCF growth 3Y-4.03%
OCF growth 5Y6.98%
BIO-TECHNE CORP / TECH FAQ
Can you provide the ChartMill fundamental rating for BIO-TECHNE CORP?
ChartMill assigns a fundamental rating of 6 / 10 to TECH.
What is the valuation status of BIO-TECHNE CORP (TECH) stock?
ChartMill assigns a valuation rating of 4 / 10 to BIO-TECHNE CORP (TECH). This can be considered as Fairly Valued.
How profitable is BIO-TECHNE CORP (TECH) stock?
BIO-TECHNE CORP (TECH) has a profitability rating of 7 / 10.
What is the financial health of BIO-TECHNE CORP (TECH) stock?
The financial health rating of BIO-TECHNE CORP (TECH) is 7 / 10.
Is the dividend of BIO-TECHNE CORP sustainable?
The dividend rating of BIO-TECHNE CORP (TECH) is 4 / 10 and the dividend payout ratio is 62.38%.